On the occasion of the release of its first quarter results, Medtronic expects to increase its adjusted EPS target range for the full year by 10 cents to $ 5.54 and $ 5.60, respectively. , $ 44 and $ 5.50.The provider of medical equipment Dublin also confirms a growth of its annual revenues of about 4% on an organic basis, excluding a negative exchange rate effect that would be 0.8 or 1.2 points.
In the first three months of 2019-20, Medtronic posted adjusted EPS up 8% to $ 1.26 per share, for revenue up 1.5% to $ 7.49 billion (+3, 5% organic).
Copyright (c) 2019 CercleFinance.com. All rights reserved.
Source link
https://www.zonebourse.com/MEDTRONIC-PLC-20661655/actualite/Medtronic-relevement-de-la-fourchette-cible-de-BPA-29089609/
